Clinical Trial

A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 5, 2023 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL. The main question it aims to answer are: •Whether Chi-BEAM improves patient survival compared to BEAM group Participants will be given BEAM or Chi-BEAM before ASCT. Researchers will compare the efficacy and safety of the two groups.
Trial Details
NCT Number NCT05931263
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Newly Diagnosed Peripheral T-cell Lymphoma
Enrollment 104 participants
Start Date 2023-06-01
Primary Completion 2026-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2023-07-05